Showing results (221-230 of 4,123) with videos related to
Sort By:
Pageof 413
Journal of Biological Response Modifiers|April 1, 1985
Induction by interferon-alpha of tumoricidal activity of adherent mononuclear cells from human blood: monocytes as responder and effector cellsS Sone, T Utsugi, T Shirahama, et al.Head & Neck|January 16, 1999
Parotid gland lesions: diagnosis of malignancy with MRI and flow cytometric DNA analysis and cytology in fine-needle aspiration biopsyS Takashima, F Takayama, Q Wang, et al.Oncology|September 1, 1994
Spontaneous production of interleukin-8 by human lung cancer cells and its augmentation by tumor necrosis factor alpha and interleukin-1 at protein and mRNA levelsK Mizuno, S Sone, E Orino, et al.International Journal of Cancer|July 9, 1993
M-CSF gene transduction in multidrug-resistant human cancer cells to enhance anti-P-glycoprotein antibody-dependent macrophage-mediated cytotoxicityY Heike, S Sone, S Yano, et al.Thyroid : Official Journal of the American Thyroid Association|July 25, 2000
Primary thyroid lymphoma: diagnosis of immunoglobulin heavy chain gene rearrangement with polymerase chain reaction in ultrasound-guided fine-needle aspirationS Takashima, F Takayama, A Saito, et al.Investigative Radiology|April 14, 2000
Head and neck lesions: determination of an optimal MT technique for prediction of malignanciesS Takashima, F Takayama, Q Wang, et al.Nippon Ganka Gakkai Zasshi|June 11, 1999
[Effects of local administration of interferon-beta on proliferation of the retinal pigment epithelium]T Kimoto, K Takahashi, T Tobe, et al.American Journal of Respiratory and Critical Care Medicine|December 10, 1999
Markers indicating deterioration of pulmonary Mycobacterium avium-intracellulare infectionY Yamazaki, K Kubo, A Takamizawa, et al.Cancer Immunology, Immunotherapy : CII|September 29, 1999
Vascular endothelial growth factor in malignant pleural effusion associated with lung cancerH Yanagawa, E Takeuchi, Y Suzuki, et al.Cytokine|January 9, 2001
Interleukin (IL-)15 has less activity than IL-2 to promote type 2 cytokine predominance in tumour-associated mononuclear cells from lung cancer patientsE Takeuchi, H Yanagawa, Y Suzuki, et al.Pageof 413